Plaud NotePin vs Heidi Remote vs Omi: wearable AI scribe devices for clinicians compared (2026)

Dr Kola Tytler (MBBS CertHE MBA MRCGP)||13 min read
Featured image for Plaud NotePin vs Heidi Remote vs Omi: wearable AI scribe devices for clinicians compared (2026)

Key takeaways

  • Plaud NotePin S is the most mature clinical-grade wearable scribe: 1.5 million users, HIPAA/GDPR/SOC 2/ISO 27001 certified, 30+ SOAP and specialty templates, and hardware that has been refined across three product generations. It is the safe, established choice.
  • Heidi Remote is the newest entrant, launched 19 March 2026 by Heidi Health (valued at $700M+). Its differentiator is on-device transcription via Argmax, meaning audio never needs to leave the device during the consultation. It plugs into Heidi's broader platform (Scribe, Evidence, Comms). It is the most privacy-forward option — but also the least battle-tested.
  • Omi is an open-source, $89 pendant-sized device with surprisingly mature compliance (HIPAA, SOC 2). It is infinitely customisable via community plugins but requires technical confidence. It is the budget/hacker option — not yet a serious clinical-grade tool for most clinicians.
  • None of these devices replaces your clinical knowledge tool. They capture what is said; they do not tell you what to do. A wearable scribe paired with a clinical reference tool like iatroX — for rapid guideline checks, differential diagnosis support, and exam preparation — is a more complete clinical AI workflow than any single-vendor stack.

Why this comparison matters now

Until very recently, every AI scribe was a piece of software. You opened an app, a browser extension, or a desktop client, hit record on your phone or laptop, and the audio was captured by a general-purpose device you already owned.

That has changed. In the space of a few months, three fundamentally different approaches to dedicated AI scribe hardware have emerged — each with a different philosophy about how clinical audio should be captured, processed, and stored. For clinicians evaluating these tools, the differences are not cosmetic. They affect privacy, workflow, cost, regulatory compliance, and clinical utility.

This is the first clinician-focused, head-to-head comparison of all three.

The contenders at a glance

FeaturePlaud NotePin SHeidi RemoteOmi
ManufacturerPlaud AI (Shenzhen)Heidi Health (Melbourne)Open-source community
Form factorClip-on / lanyard / wristband / magnetic pinLapel clip (details TBC)Pendant / clip
LaunchNotePin S: Feb 2026 (3rd gen)March 2026 (1st gen)2024 (ongoing)
Price (device)~$169 (NotePin S)TBC~$89
SubscriptionFree (300 min/mo) or $79–$159/yrTBC (likely tied to Heidi Pro at $99/mo)Free (open-source); optional paid AI
TranscriptionCloud (GPT-5.2, Claude Sonnet 4.5, Gemini 3 Pro)On-device (Argmax) + cloud for notesCloud (multiple LLM options)
Offline recordingYes (64GB local storage)Yes (primary mode)Yes (syncs via phone)
Offline transcriptionNo (syncs then transcribes)Yes (on-device ASR)No
Clinical templates30+ (SOAP, specialty-specific)Full Heidi template libraryCommunity-built; no clinical default
HIPAAYesYes (Heidi platform)Yes (claimed)
GDPRYesYes (Heidi platform)Yes (claimed)
SOC 2Type 2TBCYes (claimed)
ISO 27001YesTBCNo
MHRA registeredNo (not a medical device claim)TBCNo
Speaker identificationYesTBCYes (via plugins)
EHR integrationNo native push (copy/paste)Via Heidi platformNo (developer-built)
Broader platformStandalone + Ask Plaud AIHeidi Scribe + Evidence + CommsStandalone + plugins

Plaud NotePin S: the established clinical workhorse

What it is

Plaud NotePin S is the third-generation wearable from Plaud AI, a Shenzhen-based company that has shipped over 1.5 million devices globally. The NotePin S is a small, lightweight clip-on device with four wearable accessories (lanyard, wristband, clip, magnetic pin), a tactile record button, and a "Press to Highlight" feature that lets clinicians mark key moments during a consultation.

How it works for clinicians

The workflow is straightforward: clip the device on, press the button to start recording, and the NotePin S captures multi-speaker audio with speaker identification. After the consultation, the audio syncs to the Plaud app via Bluetooth, where it is transcribed using a multi-model AI pipeline (GPT-5.2, Claude Sonnet 4.5, Gemini 3 Pro). The transcript is then processed into structured clinical notes using one of 30+ templates, including SOAP notes and specialty-specific formats for ER, psychotherapy, general practice, and more.

The device has 64GB of local storage, so it can record an entire day of consultations without syncing. However, transcription itself happens in the cloud — the device stores raw audio locally but does not process it on-device.

Strengths for clinicians

  • Maturity: Three product generations means the hardware, firmware, and app have been refined through real-world use. Edge cases (battery life, audio quality in noisy environments, multi-speaker separation) have been iterated on.
  • Clinical template library: 30+ pre-built templates with the ability to create custom templates. This is the most comprehensive clinical template offering of any wearable scribe device.
  • Compliance breadth: HIPAA, GDPR, SOC 2 Type 2, ISO 27001, ISO 27701, and EN 18031. This is a compliance stack that will satisfy most NHS Trust information governance teams and US health system security reviews.
  • "Ask Plaud" feature: An AI assistant within the app that can answer questions about the transcript, extract specific findings, or summarise from different perspectives.
  • Price: The device is a one-time purchase (~$169 for NotePin S). The free tier includes 300 minutes of transcription per month. Paid plans ($79–$159/year) unlock unlimited transcription and advanced features. This is significantly cheaper than most subscription-based scribes.

Limitations for clinicians

  • No on-device transcription: Audio must be synced to the cloud for processing. This means there is a delay between the end of the consultation and the availability of the note, and the audio does traverse the internet.
  • No native EHR integration: Notes are generated in the Plaud app and must be copied/pasted into the clinical record. There is no direct write-back to EMIS, SystmOne, Epic, or other EHR systems.
  • Not purpose-built for clinical use: Plaud is a general-purpose AI note-taker that has added clinical features. It is used by salespeople, lawyers, journalists, and students as well as clinicians. The clinical templates are good, but the device and app were not designed from the ground up for healthcare workflows.
  • Magnetic components: The NotePin S contains magnets. Plaud's own documentation warns that users with pacemakers should avoid wearing it on the chest. This is a meaningful consideration for clinicians who may also be patients.
  • No MHRA registration: Plaud does not claim medical device status. For NHS organisations that require MHRA-registered tools following the NHS England guidance on ambient scribes, this is a gap.

Heidi Remote: the privacy-first platform play

What it is

Heidi Remote is a dedicated wearable device launched on 19 March 2026 by Heidi Health, the Melbourne-based clinical AI company valued at over $700 million. The device is designed to capture consultations with a single button press and run speech-to-text transcription entirely on-device, using AI models deployed in partnership with Argmax.

How it works for clinicians

The key differentiator is the on-device transcription. When a clinician presses the button and starts a consultation, the audio is captured, transcribed locally, and stored encrypted on the device — with no dependency on a phone, browser, or internet connection. After the consultation, when connectivity is available, the transcript syncs to the Heidi platform, where it is processed into structured clinical notes using Heidi's cloud-based AI (built in part on Anthropic's Claude models).

Heidi Remote plugs into Heidi's broader ecosystem: Heidi Scribe for documentation, Heidi Evidence for clinical reference (partnered with NICE, BMJ Group, MIMS, and HealthPathways), and Heidi Comms for patient communications.

Strengths for clinicians

  • On-device transcription: The single strongest privacy feature of any wearable scribe. Audio never needs to leave the device during the consultation. End-of-session latency is under one second regardless of session length or connectivity.
  • Platform integration: Unlike Plaud (standalone device) or Omi (standalone device), Heidi Remote feeds into a full clinical workflow — documentation, evidence, and communications in one ecosystem.
  • Clinical pedigree: Heidi's platform has supported over 100 million clinical interactions and 2.4 million consultations per week. The company was founded by a vascular surgical registrar. The platform is designed specifically for healthcare.
  • Connectivity independence: Works identically in a connected urban practice and a remote rural clinic with no Wi-Fi. This is particularly relevant for Australian rural practice, Canadian northern territories, and NHS sites with poor internal connectivity.
  • Automedica acquisition and MHRA AI Airlock access: Heidi's acquisition of Automedica gives it access to the UK MHRA AI Airlock, which may accelerate its regulatory pathway in the UK market.

Limitations for clinicians

  • First-generation device: Heidi Remote has just launched. There is no track record of real-world reliability, battery endurance, audio quality in noisy clinical environments, or firmware stability. First-generation hardware from any vendor carries risk.
  • Pricing unknown: Heidi has not published pricing for the Remote device or clarified whether it is bundled with a Heidi subscription or sold separately. Given Heidi Pro costs $99/month per clinician, the total cost of ownership could be significantly higher than Plaud.
  • Platform lock-in: Heidi Remote feeds exclusively into the Heidi ecosystem. You cannot use it with Tortus, Accurx Scribe, Nabla, or any other documentation platform. If you adopt Remote, you are committing to Heidi's entire stack.
  • Cloud still processes notes: On-device transcription gets you a raw transcript. The structured clinical note is still generated in the cloud. The privacy benefit is real but bounded — see our detailed analysis of on-device clinical AI and data privacy.
  • Regulatory status unclear: It is not yet confirmed whether Heidi Remote itself requires MHRA registration, FDA clearance, or TGA listing as a medical device or whether it is classified as a general-purpose recording device.

Omi: the open-source wildcard

What it is

Omi is an open-source, pendant-sized wearable AI device priced at $89. Both the hardware design and the software are open-source, meaning anyone can modify, extend, or build upon the platform. The community has built plugins for diverse use cases, including sales coaching, translation, sleep analysis, and — relevantly — clinical documentation.

How it works for clinicians

Omi pairs with the clinician's smartphone via Bluetooth, captures audio, and syncs recordings to cloud-based AI for transcription and note generation. The device does not perform on-device transcription. The open-source software supports multiple LLM backends, and the community has built plugins that can generate SOAP-style notes, although these are not as polished or clinically validated as Plaud's or Heidi's templates.

Strengths for clinicians

  • Price: At $89, Omi is less than half the cost of Plaud NotePin S and likely a fraction of Heidi Remote. For a clinician who wants to experiment with wearable scribing without a significant financial commitment, Omi is the lowest-risk entry point.
  • Open-source flexibility: If you have technical skills (or access to someone who does), you can build custom clinical workflows, integrate with specific EHR systems, or modify the transcription pipeline to suit your needs.
  • Compliance claims: Omi claims HIPAA compliance and SOC 2 certification, which is surprisingly mature for an open-source project. However, these claims should be independently verified by any organisation considering clinical deployment.
  • Community innovation: After Meta acquired Limitless (a competing wearable), many users migrated to Omi. The community is active and growing, with new plugins and integrations appearing regularly.
  • No vendor lock-in: Because everything is open-source, there is no risk of the vendor disappearing or changing terms. The community can maintain and develop the software independently.

Limitations for clinicians

  • Not clinically validated: Omi was not designed for healthcare. The clinical documentation plugins are community-built, not professionally developed or validated against clinical accuracy standards.
  • No clinical template library: There are no pre-built, specialty-specific clinical templates comparable to Plaud's 30+ options or Heidi's template system.
  • Compliance verification needed: While Omi claims HIPAA and SOC 2 compliance, these should be independently verified. Open-source compliance is complex — the platform may be compliant, but individual plugins or custom deployments may introduce vulnerabilities.
  • Phone dependency: Omi requires a paired smartphone to function. It does not work independently like Heidi Remote.
  • No MHRA, FDA, or TGA registration: Omi makes no medical device claims and has no regulatory registration in any jurisdiction.
  • Support: There is no vendor support team. Support comes from the community via Discord and GitHub. For a busy clinician who needs a tool that "just works," this is a significant drawback.

Which device for which clinician?

The UK GP who needs NHS-compliant documentation

Our recommendation: Wait — or use Plaud cautiously alongside established software scribes.

The NHS England guidance on ambient scribes mandates MHRA-registered tools with clinical safety cases (DCB0129) and organisational risk assessments (DCB0160). None of these three wearable devices currently meets this standard. For formal NHS deployment, software-based scribes like Tortus (MHRA Class I, IIa pending), Accurx Scribe (MHRA Class I), or Heidi's software-based scribe remain the safer option.

If you want to experiment personally (outside formal NHS governance), Plaud NotePin S has the broadest compliance documentation and the most mature clinical template library.

The US physician who wants a HIPAA-compliant wearable

Our recommendation: Plaud NotePin S.

Plaud's HIPAA compliance is well-documented, the device is available now, the clinical template library is comprehensive, and the pricing is transparent and affordable. The NotePin S's "Press to Highlight" feature is genuinely useful for marking key moments in a long consultation. The lack of EHR integration is a friction point, but the same is true of all three devices.

The Australian GP in a rural or remote practice

Our recommendation: Watch Heidi Remote closely.

Heidi is an Australian company, its platform is widely used in Australian general practice, and the on-device transcription solves the connectivity problem that is most acute in rural and remote Australia. However, we would recommend waiting for real-world reviews and confirmed pricing before committing to a first-generation device.

The tech-savvy clinician who wants to build a custom workflow

Our recommendation: Omi — with caveats.

If you are comfortable with open-source tools, understand the compliance implications, and want to build a bespoke clinical documentation pipeline that integrates with your specific EHR or workflow, Omi offers unmatched flexibility at the lowest price. But it is not a plug-and-play clinical tool, and you should not deploy it in a clinical setting without conducting your own compliance assessment.

The trainee or medical student

Our recommendation: Plaud NotePin S (for lecture capture and study) + iatroX (for clinical knowledge and exam prep).

Plaud's free tier (300 minutes/month) is generous enough for lecture capture and study sessions. Pair it with iatroX's adaptive Quiz for UKMLA, MRCP, USMLE Step 2 CK, or MCCQE revision, and you have a study workflow that captures everything and tests your understanding.

The bigger picture: hardware is the capture layer, not the knowledge layer

All three of these devices do the same fundamental thing: they capture what is said in a clinical encounter and turn it into a structured note. This is valuable. The time savings are real — and well-evidenced across the AI scribe literature.

But capturing what was said is not the same as knowing what to do. A wearable scribe does not tell you which investigation to order, which guideline applies, or whether the presentation warrants urgent referral. For that, you need a clinical knowledge and reasoning tool.

This is where iatroX fits. It is free, MHRA-registered, and designed to provide rapid, evidence-based answers grounded in NICE, CKS, SIGN, and BNF guidelines — through Ask iatroX for clinical Q&A, Brainstorm for differential diagnosis support, and the iatroX Knowledge Centre for curated guideline navigation. It works on any device you already own — no additional hardware required.

A wearable scribe captures the conversation. iatroX helps you have the right one.

Related reading on iatroX

Share this insight